Myelogenous Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2016-04-29
New treatment for rare white blood cell cancer
The EMA announces a new treatment for a rare white blood cell cancer, representing a targeted option for this rare indication.